000			02176 a2200601 4500
005			20250514022447.0
264		0	_c20020212
008			200202s 0 0 eng d
022			_a0020-7136
024	7		_a10.1002/ijc.1628 _2doi
040			_aNLM _beng _cNLM
100	1		_aGalmarini, Carlos María
245	0	0	_aExpression of a non-functional p53 affects the sensitivity of cancer cells to gemcitabine. _h[electronic resource]
260			_bInternational journal of cancer _cFeb 2002
300			_a439-45 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdenocarcinoma _xpathology
650	0	4	_aAntimetabolites, Antineoplastic _xpharmacology
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aBreast Neoplasms _xpathology
650	0	4	_aCyclin-Dependent Kinase Inhibitor p21
650	0	4	_aCyclins _xbiosynthesis
650	0	4	_aDNA Damage
650	0	4	_aDNA Replication _xdrug effects
650	0	4	_aDNA, Neoplasm _xdrug effects
650	0	4	_aDeoxycytidine _xanalogs & derivatives
650	0	4	_aDrug Resistance, Neoplasm _xgenetics
650	0	4	_aFemale
650	0	4	_aG1 Phase _xdrug effects
650	0	4	_aGene Expression Regulation, Neoplastic _xdrug effects
650	0	4	_aGenes, Dominant
650	0	4	_aGenes, bcl-2
650	0	4	_aGenes, p53
650	0	4	_aHumans
650	0	4	_aNeoplasm Proteins _xdeficiency
650	0	4	_aNeoplastic Stem Cells _xdrug effects
650	0	4	_aPhenotype
650	0	4	_aProto-Oncogene Proteins c-bcl-2 _xbiosynthesis
650	0	4	_aRNA, Messenger _xbiosynthesis
650	0	4	_aRNA, Neoplasm _xbiosynthesis
650	0	4	_aS Phase _xdrug effects
650	0	4	_aTumor Cells, Cultured _xdrug effects
650	0	4	_aTumor Suppressor Protein p53 _xdeficiency
650	0	4	_abcl-X Protein
650	0	4	_aGemcitabine
700	1		_aClarke, Marilyn L
700	1		_aFalette, Nicole
700	1		_aPuisieux, Alain
700	1		_aMackey, John R
700	1		_aDumontet, Charles
773	0		_tInternational journal of cancer _gvol. 97 _gno. 4 _gp. 439-45
856	4	0	_uhttps://doi.org/10.1002/ijc.1628 _zAvailable from publisher's website
999			_c11713056 _d11713056